Priming interleukin 8 production: Role of platelet-activating factor and p38

Archives of Surgery

Volumn 134, Issue 12, 1999, Pages 1348-1353

  Arbabi, Saman ^a   Rosengart, Matthew R ^a   Garcia, Iris ^a   Jelacic, Sandra ^a   Maier, Ronald V ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; SYNAPTOPHYSIN; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0032760737     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.12.1348     Document Type: Article

References (40)

1. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV. Multiple-organ-failure syndrome. Arch Surg. 1986;121:196-208.
2. Baue AE. Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome: why no magic bullets? Arch Surg. 1997; 132:703-707.
3. Fry DE, Pearlstein L, Fulton RL, Polk HC Jr. Multiple system organ failure: the role of uncontrolled infection. Arch Surg. 1980;115:136-140.
4. Pinner RW, Teutsch SM, Simonsen L, et al. Trends in infectious diseases mortality in the United States. JAMA. 1996;275:189-193.
5. Ulevitch RJ, Tobias PS. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol. 1999;11:19-22.
6. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/ 10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085-2088.
7. Snyder F. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim Biophys Acta. 1995;1254:231-249.
8. Iñarrea P, Gomez-Cambronero J, Pascual J, del Carmen Ponte M, Hernando L, Sanchez-Crespo M. Synthesis of PAF-acether and blood volume changes in Gram-negative sepsis. Immunopharmacology. 1985;9:45-52.
9. Bessin P, Bonnet J, Apffel D, et al. Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. Eur J Pharmacol. 1983;86:403-413.
10. Gonzalez-Crussi F, Hsueh W. Experimental model of ischemic bowel necrosis: the role of platelet-activating factor and endatoxin. Am J Pathol. 1983;112:127-135.
11. Doebber TW, WU MS, Biftu T. Platelet-activating factor [PAF] mediation of rat anaphylactic response to soluble immune complexes: studies with PAF receptor antagonist L-652,731. J Immunol. 1986;136:4659-4668.
12. Hwang S-B. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms. J Lipid Mediat. 1990;2:123-158.
13. Maier RV, Hahnel GB, Fletcher JR. Platelet-activating factor augments tumor necrosis factor and procoagulant activity. J Surg Res. 1992;52:258-264.
14. Salem P, Deryckx S, Dulioust A, et al. Immunoregulatory function of PAF-acether, IV: enhancement of IL-1 production by muramyl dipeptide-stimulated monocytes. J Immunol. 1990;144:1338-1344.
15. Osterud B. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: requirement of platelets and granulocytes. J Leukoc Biol. 1992;51:462-465.
16. Glaser KB, Asmis R, Dennis EA. Bacterial lipopolysaccharide priming of p388D1: macrophage-like cells for enhanced arachidonic acid metabolism. J Biol Chem. 1990;265:8658-8664.
17. Huber AR, Kunkel SL, Todd RF III, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science. 1991;254:99-102.
18. Wu L, Ruffing N, Shi X, Newman W, Soler D, Mackay CR, Qin S. Discrete steps in binding and signaling of interleukin-8 with its receptor. J Biol Chem. 1996; 271:31202-31209.
19. Knall C, Young S, Nick JA, Buhl AM, Worthen GS, Johnson GL. Interleukin-8 regulation of the ras/raf/mitogen-activated protein kinase pathway in human neutrophils. J Biol Chem. 1996;271:2832-2838.
20. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994;265:808-811.
21. Shapiro L, Dinarello CA. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci U S A. 1995;92:12230-12234.
22. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinylimidazoles. Biochem Biophys Res Commun. 1997;235:533-538.
23. LI Z, Jiang Y, Ulevitch RJ, Han J. The primary structure of p38g: a new member of p38 group of MAP kinase. Biochem Biophys Res Commun. 1996;228:334-340.
24. Sage SO, Rink TJ. The kinetics of changes in intracellular calcium concentration in Fura-2-loaded human platelets. J Biol Chem. 1987;262:16364-16369.
25. Nick JA, Avdi NJ, Young SK, et al. Common and distinct intracellular signaling pathways in human neutropbils utilized by platelet activating factor and FMLP. J Clin Invest. 1997;99:975-986.
26. Matsumoto K, Hashimoto S, Gon Y, Nakayama T, Horie T. Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase-dependent pathway. J Allergy Clin Immunol. 1998;101:825-831.
27. Prichett W, Hand A, Shields J, Dunnington D. Mechanism of action of bicyclic imidazoles defines a translational regulation pathway for tumor necrosis factor alpha. J Inflamm. 1995;45:97-105.
28. Lee JC, Laydon JT, McDonnell PC, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994;372:739-746.
29. Prpic V, Uhing RJ, Weiel JE, et al. Biochemical and functional responses stimulated by platelet-activating factor in murine peritoneal macrophages. J Cell Biol. 1988;107:363-372.
30. Ward SG, Westwick J. Antagonism of the platelet-activating factor-induced rise of the intracellular calcium ion concentration of U937 cells. Br J Pharmacol. 1988; 93:769-774.
31. 2+ mobilization and eicosanoid release in human Mono Mac 6 cells. J Immunol. 1992;148:2186-2193.
32. Goodman ER, Kleinstein E, Fusco AM, et al. Role of interleukin 8 in the genesis of acute respiratory distress syndrome through an effect on neutrophil apoptosis. Arch Surg. 1998;133:1234-1239.
33. Miller EJ, Cohen AB, Matthay MA. Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis. Crit Care Med. 1996;24:1448-1454.
34. Kiehl MG, Ostermann H, Thomas M, Muller C, Cassens U, Kienast J. Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome. Crit Care Med. 1998;26:1194-1199.
35. Fukumoto T, Matsukawa A, Yoshimura T, et al. IL-8 is an essential mediator of the increased delayed-phase vascular permeability in LPS-induced rabbit pleurisy. J Leukoc Biol. 1998;63:584-590.
36. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome. Chest. 1995;108:1303-1314.
37. Arbabi S, Garcia I, Bauer GJ, Maier RV. Alcohol (ethanol) inhibits IL-8 and TNF: role of the p38 pathway. J Immunol. 1999;162:7441-7445.
38. Deforge LE, Fantone JC, Kenny JS, Remick DG. Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. J Clin Invest. 1992; 90:2123-2129.
39. DeCoster MA, Mukherjee PK, Davis RJ, Bazan NG. Platelet-activating factor is a downstream messenger of Kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons. J Neurosci Res. 1998;53:297-303.
40. Bonaccorsi L, Luconi M, Maggi M, et al. Protein tyrosine kinase, mitogen-activated protein kinase and protein kinase C are involved in the mitogenic signaling of platelet-activating factor (PAF) in HEC-1A cells. Biochim Biophys Acta. 1997;1355:155-166.